Characteristics of outpatient nirmatrelvir/ritonavir recipients during the 2022/2023 era in Alberta, Canada: A retrospective observational population-based study.

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/42621961

Elissa Rennert-May; Ellen Rafferty; Jason Randall; Jenine Leal; Karen Martins; Khanh Vu; Lynora Saxinger; Phuong Uyen Nguyen; Scott Klarenbach; Sylvia Aponte-Hao; Tyler Williamson

Aug 21, 2026